logo-loader
NASDAQ:ADAP

Adaptimmune Therapeutics PLC

Receive alerts
Market:
NASDAQ
Market Cap:
$183.97 m
Price
$1.75
Change
0.00%
52 weeks high
14.52
52 weeks low
1.38

In brief

Adaptimmune is a clinical-stage biopharmaceutical company focused on the development of novel cancer immunotherapy products for cancer patients.